Multidrug-Resistant Acinetobacter: Detection of ESBL, MBL, blaNDM-1 Genotype, and Biofilm Formation at a Tertiary Care Hospital in Eastern Nepal

Background The Acinetobacter species is an important hospital-acquired pathogen. The rapid development of resistance to multiple drugs and the ability to form biofilm make these bacteria more adaptable to survive in healthcare facilities, thus posing a challenge to their effective management. Objective This study aimed to characterize clinical isolates of Acinetobacter spp and to study their antimicrobial susceptibility patterns and ability to form biofilm. Resistant Acinetobacter was further analyzed for the detection of extended-spectrum β-lactamases (ESBLs), metallo β-lactamases (MBLs), carbapenemase production, and presence of blaNDM-1 gene. Materials and Methods A total of 324 Acinetobacter species were isolated from various clinical specimens which were submitted to the Department of Microbiology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal, and were studied for antibiotic susceptibility testing, detection of ESBL and MBL production, and formerly biofilm formation was performed by standard microbiological methods. PCR was carried out to determine the presence of the blaNDM-1 gene. Results The predominant Acinetobacter species isolated was A calcoaceticus-baumannii Complex (Acb complex) 167 (51.5%). Among those, all A. species 128 (40%) were multidrug resistant (MDR). In which 13 (4.0%) were ESBL producers, 70 (61.9%) were MBL, and 12 (10.6%) were carbapenemases producers. The blaNDM1 gene was present in 33 isolates. Thirty-seven percent (121/324) of isolates formed biofilm. The majority of A. species were resistant to cefotaxime 73.8% (239) and cefepime 74.4% (241). A significant proportion of biofilm producers were MDR (p < 0.001). Conclusion Drug-resistant Acinetobacter formed a substantial proportion of this hospital's samples with a large presence of the blaNDM-1 gene. A matter of great concern is the association of multidrug-resistant phenotype with biofilm formation. This situation warranted stringent surveillance and adherence to infection prevention and control practices.

[1]  S. Awad,et al.  Epidemiology of Biofilm Producing Acinetobacter baumannii Nosocomial Isolates from a Tertiary Care Hospital in Egypt: A Cross-Sectional Study , 2021, Infection and drug resistance.

[2]  Ehab Azab,et al.  Prevalence of Aminoglycoside Resistance and Aminoglycoside Modifying Enzymes in Acinetobacter baumannii Among Intensive Care Unit Patients, Ismailia, Egypt , 2021, Infection and drug resistance.

[3]  R. Ranjbar,et al.  Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran , 2019, Antimicrobial Resistance & Infection Control.

[4]  R. Shapouri,et al.  Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients , 2019, BMC Infectious Diseases.

[5]  M. Bassetti,et al.  Treatment of Infections Due to MDR Gram-Negative Bacteria , 2019, Front. Med..

[6]  L. Bielen,et al.  FALSE POSITIVE PHENOTYPIC DETECTION OF METALLO-BETA-LACTAMASES IN ACINETOBACTER BAUMANNII , 2018, Acta clinica Croatica.

[7]  N. Bhattarai,et al.  Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study , 2018, Antimicrobial Resistance & Infection Control.

[8]  Supriya Sharma,et al.  Prevalence of the blaNDM gene among metallo-β-lactamase-producing Gram-negative isolates from western Nepal. , 2018, Journal of global antimicrobial resistance.

[9]  S. Yadav.  ANTIBIOGRAM OF BIOFILM PRODUCER ACINETOBACTER ISOLATES FROM DIFFERENT CLINICAL SPECIMENS , 2018 .

[10]  N. Shaikh,et al.  Multidrug-Resistant Acinetobacter , 2017 .

[11]  A. Farahani,et al.  Frequency of Class 1 Integron and Genetic Diversity of Acinetobacter baumannii Isolated from Medical Centers in Kermanshah , 2017, Journal of natural science, biology, and medicine.

[12]  M. Radha,et al.  Evaluation of Biofilm Production in Acinetobacter baumannii with Reference to Imipenem Resistance , 2017 .

[13]  R. Bonomo,et al.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges , 2016, Clinical Microbiology Reviews.

[14]  A. Rickard,et al.  Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces , 2016, Letters in applied microbiology.

[15]  R. Mirnejad,et al.  Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance , 2016 .

[16]  A. Farahani,et al.  Evaluate the frequency distribution of nonadhesive virulence factors in carbapenemase-producing Acinetobacter baumannii isolated from clinical samples in Kermanshah , 2016, Journal of natural science, biology, and medicine.

[17]  Amatya.  Prevalence of tigecycline resistant multidrug resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex from a tertiary care hospital in Nepal , 2016 .

[18]  M. Parani,et al.  Molecular Detection of New Delhi Metallo-Beta-Lactamase-1 (NDM-1) Positive Bacteria from Environmental and Drinking Water Samples by Loop Mediated Isothermal Amplification of blaNDM-1 , 2015, Indian Journal of Microbiology.

[19]  M. Alikhani,et al.  Prevalence of ESBL and MBL encoding genes in Acinetobacter baumannii strains isolated from patients of intensive care units (ICU) , 2015, Saudi journal of biological sciences.

[20]  M. Feizabadi,et al.  Clonal evolution multi-drug resistant Acinetobacter baumannii by pulsed-field gel electrophoresis , 2015, Indian journal of medical microbiology.

[21]  Neetu Gupta,et al.  Isolation and identification of Acinetobacter species with special reference to antibiotic resistance , 2015, Journal of natural science, biology, and medicine.

[22]  G. K. Badave,et al.  Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging Challenge. , 2015, Journal of clinical and diagnostic research : JCDR.

[23]  P. Nordmann,et al.  Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria , 2014, BioMed research international.

[24]  L. Mundy,et al.  Emergence of New Delhi metallo-β-lactamase type 1-producing enterobacteriaceae and non-enterobacteriaceae: global case detection and bacterial surveillance. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[25]  S. Anwar,et al.  Association of Biofilm Formation with Antimicrobial Resistance Among the Acinetobacter Species in A Tertiary Care Hospital in Bangladesh , 2013 .

[26]  B. Khanal,et al.  Acinetobacter Species: Phenotypic Characterization And Antimicrobial Resistance , 2013 .

[27]  M. Grinholc,et al.  Innovative Strategies to Overcome Biofilm Resistance , 2012, BioMed research international.

[28]  Wolfgang Kohnen,et al.  Infections Associated with Medical Devices , 2012, Drugs.

[29]  Prof. M.R Shakibaie,et al.  Antibiotic resistance patterns and extended-spectrum β-lactamase production among Acinetobacter spp. isolated from an intensive care Unit of a hospital in Kerman, Iran , 2012, Antimicrobial Resistance and Infection Control.

[30]  Paolo Visca,et al.  Acinetobacter infection – an emerging threat to human health , 2011, IUBMB life.

[31]  N. Malik,et al.  Modified Hodge test: A simple and effective test for detection of carbapenemase production , 2011, Iranian journal of microbiology.

[32]  P. Nordmann,et al.  Genetic Features of blaNDM-1-Positive Enterobacteriaceae , 2011, Antimicrobial Agents and Chemotherapy.

[33]  S. Zinjarde,et al.  Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. , 2011, FEMS immunology and medical microbiology.

[34]  Clinical,et al.  Performance standard for antimicrobial susceptibility testing. , 2010 .

[35]  Jordi Rello,et al.  International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.

[36]  S. Stepanović,et al.  Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[37]  A. Basson,et al.  Evaluation of Adherence, Hydrophobicity, Aggregation, and Biofilm Development of Flavobacterium johnsoniae-Like Isolates , 2007, Microbial Ecology.

[38]  B. Jansen,et al.  Infections associated with medical devices: pathogenesis, management and prophylaxis. , 2005, Drugs.

[39]  H. Shin,et al.  Imipenem-EDTA Disk Method for Differentiation of Metallo-β-Lactamase-Producing Clinical Isolates of Pseudomonas spp. and Acinetobacter spp , 2002, Journal of Clinical Microbiology.

[40]  C. Solano,et al.  The Enterococcal Surface Protein, Esp, Is Involved in Enterococcus faecalis Biofilm Formation , 2001, Applied and Environmental Microbiology.

[41]  B. Millar,et al.  A simple and sensitive method to extract bacterial, yeast and fungal DNA from blood culture material. , 2000, Journal of microbiological methods.

[42]  C Washington Winn,et al.  Koneman's Color Atlas and Textbook of Diagnostic Microbiology , 1994 .

[43]  H. Sambrook.  Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .

[44]  A. Bisno,et al.  Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces , 1982, Infection and immunity.